Matches in SemOpenAlex for { <https://semopenalex.org/work/W2980161228> ?p ?o ?g. }
- W2980161228 abstract "Abstract Abstract 3301 Moesin is a member of the protein 4.1 superfamily and shares structure homology with ezrin and radixin. The phosphorylation of moesin increases the aggregation of Fas, activation of capases, and triggers the apoptotic pathways through the Rho-ROCK pathway. The moesin protein is highly expressed in human platelets and phosphorylation of threonine558 is associated with the activation of platelets. Autoantibodies against moesin have not been evaluated in patients with ITP. Thus, we designed and expressed three polypeptides of moesin: N1-297 terminal, α 298–470 helix domain and C471-577 terminal for ELISA assays. Serum samples from patients with ITP (n=148), patients with non-immune thrombocytopenia (n=32), and other patients with hematologic diseases (n=102) as well as gender-matched healthy control subjects (n=50) were evaluated. All ITP patients clinically met an eligibility of ITP minimal standardized criteria from an international working group.1 The titers of moesin autoanitbodies were significantly elevated in the sera from patients with ITP compared with healthy subjects (Mean of autoantibodies titers = N1-297 0.515/0.155; α298–470 0.252/0.159; C471-577 0.430/0.144, P < 0.01). The levels of moesin autoantibodies against N1-297 and C471-577 in ITP patients were also markedly higher than in patients with non-immune thrombocytopenia (Mean of autoantibodies titers = N-1-297 0.515/0.168; C471-577 0.430/0.103, P < 0.05). However, the titer of autoantibodies against moesin ? 298–470 helix domains was similar in ITP, non-immune thrombocytopenia and in patients with other hematologic diseases. When an autoantibody cut-off value of ±2D in normal control subjects (n=50) was assigned, the serum levels of moesin autoantibodies in ITP patients were found to be elevated in 70% (103/148) positive for N-1-297, 44% (65/148) positive for C471-577 and only 6.1% (9/148) positive for α 298–470. Moreover, patients with non-immune thrombocytopenia (n=9), anaphylactic purpura (n=11) and myelodysplasticsyndrome, MDS (n=12) were all negative for moesin autoantibodies. In other groups of patients with hematologic diseases, multiple myeloma (n=15), pure red cell aplasia (n=2), and autoimmune hemolytic anemia (n=18), only autoimmune hemolytic anemia demonstrated 4.5% (3/18) positive for N-1-297 and all were negative for C471-577. Notably, severe ITP patients with iron deficiency anemia had high serum moesin autoantibodies against N-1-297 and C471-577. We also found 15.6% (6/38) positive moesin autoantibodies against C471-577 in ITP patients with systemic lupus erythematosus (SLE). To validate the ELISA results, we examined the specificity of moesin autoantibodies in ITP by Western blot analysis. Three polypeptides of moesin were run on SDS-PAGE and transferred onto nitrocellulose membrane. The immunoblotting showed autoantibodies against ITP that specifically recognized the moesin C471-577 or N1-297 polypeptide. In conclusion, this is the first study to show the elevation of serum moesin autoantibodies in patients with ITP. We propose that moesin autoantibodies specific for C471-577/N1-297 may be specific serum biomarkers for clinical diagnosis and differentiation of ITP from non-immune thrombocytopenia and other hematologic diseases. Disclosures: No relevant conflicts of interest to declare." @default.
- W2980161228 created "2019-10-18" @default.
- W2980161228 creator A5010776860 @default.
- W2980161228 creator A5013134906 @default.
- W2980161228 creator A5013138400 @default.
- W2980161228 creator A5017801656 @default.
- W2980161228 creator A5021786710 @default.
- W2980161228 creator A5029533497 @default.
- W2980161228 creator A5029594618 @default.
- W2980161228 creator A5036295593 @default.
- W2980161228 creator A5038431825 @default.
- W2980161228 creator A5055490703 @default.
- W2980161228 creator A5056487497 @default.
- W2980161228 creator A5056539193 @default.
- W2980161228 creator A5072422290 @default.
- W2980161228 creator A5078950611 @default.
- W2980161228 creator A5081408394 @default.
- W2980161228 creator A5085466214 @default.
- W2980161228 creator A5090063319 @default.
- W2980161228 date "2011-11-18" @default.
- W2980161228 modified "2023-09-29" @default.
- W2980161228 title "Autoantibodies Directed Against Moesin C471-577/N1-297 Are Novel and Specific Biomarkers of Immune Thrombocytopenic Purpura (ITP)," @default.
- W2980161228 doi "https://doi.org/10.1182/blood.v118.21.3301.3301" @default.
- W2980161228 hasPublicationYear "2011" @default.
- W2980161228 type Work @default.
- W2980161228 sameAs 2980161228 @default.
- W2980161228 citedByCount "0" @default.
- W2980161228 crossrefType "journal-article" @default.
- W2980161228 hasAuthorship W2980161228A5010776860 @default.
- W2980161228 hasAuthorship W2980161228A5013134906 @default.
- W2980161228 hasAuthorship W2980161228A5013138400 @default.
- W2980161228 hasAuthorship W2980161228A5017801656 @default.
- W2980161228 hasAuthorship W2980161228A5021786710 @default.
- W2980161228 hasAuthorship W2980161228A5029533497 @default.
- W2980161228 hasAuthorship W2980161228A5029594618 @default.
- W2980161228 hasAuthorship W2980161228A5036295593 @default.
- W2980161228 hasAuthorship W2980161228A5038431825 @default.
- W2980161228 hasAuthorship W2980161228A5055490703 @default.
- W2980161228 hasAuthorship W2980161228A5056487497 @default.
- W2980161228 hasAuthorship W2980161228A5056539193 @default.
- W2980161228 hasAuthorship W2980161228A5072422290 @default.
- W2980161228 hasAuthorship W2980161228A5078950611 @default.
- W2980161228 hasAuthorship W2980161228A5081408394 @default.
- W2980161228 hasAuthorship W2980161228A5085466214 @default.
- W2980161228 hasAuthorship W2980161228A5090063319 @default.
- W2980161228 hasConcept C142669718 @default.
- W2980161228 hasConcept C1491633281 @default.
- W2980161228 hasConcept C159654299 @default.
- W2980161228 hasConcept C163764329 @default.
- W2980161228 hasConcept C196509110 @default.
- W2980161228 hasConcept C203014093 @default.
- W2980161228 hasConcept C2776292417 @default.
- W2980161228 hasConcept C2779771385 @default.
- W2980161228 hasConcept C2780246058 @default.
- W2980161228 hasConcept C2993327898 @default.
- W2980161228 hasConcept C3018697912 @default.
- W2980161228 hasConcept C55493867 @default.
- W2980161228 hasConcept C71924100 @default.
- W2980161228 hasConcept C86803240 @default.
- W2980161228 hasConcept C8891405 @default.
- W2980161228 hasConcept C89560881 @default.
- W2980161228 hasConceptScore W2980161228C142669718 @default.
- W2980161228 hasConceptScore W2980161228C1491633281 @default.
- W2980161228 hasConceptScore W2980161228C159654299 @default.
- W2980161228 hasConceptScore W2980161228C163764329 @default.
- W2980161228 hasConceptScore W2980161228C196509110 @default.
- W2980161228 hasConceptScore W2980161228C203014093 @default.
- W2980161228 hasConceptScore W2980161228C2776292417 @default.
- W2980161228 hasConceptScore W2980161228C2779771385 @default.
- W2980161228 hasConceptScore W2980161228C2780246058 @default.
- W2980161228 hasConceptScore W2980161228C2993327898 @default.
- W2980161228 hasConceptScore W2980161228C3018697912 @default.
- W2980161228 hasConceptScore W2980161228C55493867 @default.
- W2980161228 hasConceptScore W2980161228C71924100 @default.
- W2980161228 hasConceptScore W2980161228C86803240 @default.
- W2980161228 hasConceptScore W2980161228C8891405 @default.
- W2980161228 hasConceptScore W2980161228C89560881 @default.
- W2980161228 hasLocation W29801612281 @default.
- W2980161228 hasOpenAccess W2980161228 @default.
- W2980161228 hasPrimaryLocation W29801612281 @default.
- W2980161228 hasRelatedWork W1487400623 @default.
- W2980161228 hasRelatedWork W1492395515 @default.
- W2980161228 hasRelatedWork W1510054038 @default.
- W2980161228 hasRelatedWork W1512571991 @default.
- W2980161228 hasRelatedWork W159077777 @default.
- W2980161228 hasRelatedWork W2070789650 @default.
- W2980161228 hasRelatedWork W2071867431 @default.
- W2980161228 hasRelatedWork W2801047325 @default.
- W2980161228 hasRelatedWork W3008776843 @default.
- W2980161228 hasRelatedWork W634506548 @default.
- W2980161228 hasRelatedWork W125958461 @default.
- W2980161228 hasRelatedWork W1751311850 @default.
- W2980161228 hasRelatedWork W1909748476 @default.
- W2980161228 hasRelatedWork W1919824126 @default.
- W2980161228 hasRelatedWork W1920140316 @default.
- W2980161228 hasRelatedWork W2400458418 @default.
- W2980161228 hasRelatedWork W2602043606 @default.
- W2980161228 hasRelatedWork W938256189 @default.
- W2980161228 hasRelatedWork W963714001 @default.
- W2980161228 hasRelatedWork W970943942 @default.